SGSiegfried Geyer

Siegfried Geyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siegfried Geyer has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Das Modell der Kompression der Morbidität – Hat sich die Vision erfüllt?

    by Siegfried Geyer, Jelena Epping

    Zusammenfassung: James Fries entwarf 1980 mit der These der Morbiditätskompression eine positive Vision. Es gibt vergleichsweise wenige Studien dazu. Für schwere Erkrankungen wie Herzinfarkt zeigt sich für die höheren Altersgruppen eine Kompression. Als Gegenentwicklung nehmen die Raten chronischer Erkrankungen zu. Die langzeitliche Morbiditätsentwicklung erscheint als Nebeneinander von Kompression und Expansion der Morbidität, das sowohl von Verhalten und Umgebung als auch von der Medizin getrieben wird.

  • Open Access

    Return to work or leaving work? Differences of return to work between breast cancer patients and the general population and determinants of return to work

    by Siegfried Geyer, Stefanie Sperlich, Eranda Sahiti, Dorothee Noeres

    Purpose: It was examined whether employment among breast cancer survivors was lower than in the general population 4 to 6 years after surgery. We also examined whether disease severity, post-surgical treatment, social, and workplace characteristics have effects on employment as primary outcome, and whether the distance from surgery to observation may determine employment. Methods: We performed a multicentric observational study with four survey waves. Data were collected based on mailed surveys and patient records. Patients were up to 63 years old at entry with TNM-tumour stages T0 to TIV. Comparisons with the general population were performed by drawing controls from the German Socio-Economic Panel. Results: N = 372 breast cancer survivors participated in all surveys (= 82.2% of the initial sample). Their rate of occupationally active women was lower than in the general population (ORpatients = 0.59; 95% CI = 0.42–0.84; p < 0.01). Among patients, tumour stage had no effects on employment 12 months after surgery; 4–6 years later, this was the case only among patients with the most unfavourable tumour stage (OR = 0.16; p = 0.01; 95% CI = 0.04–0.58). Antihormone therapy was unrelated with employment (OR = 0.80; p = 0.27; 95% CI = 0.54–1.19); inpatient rehabilitation was negatively associated at 12 months after surgery (OR = 0.47; p = 0.02; 95% CI = 0.25–0.89) and unrelated at the last survey wave (OR = 0.95; p = 0.86; 95% CI = 0.55–1.64). Compared with the lowest level of occupational autonomy, it was unrelated with employment 12 months after surgery (OR = 0.79; p = 0.75; 95% CI = 0.18–4.41), but for the highest level of autonomy, it had significant effects 4 to 6 years later (OR = 4.56; p = 0.04; 95% CI = 1.10–18.81). Effort-reward imbalance as a continuously scaled indicator of pre-surgery occupational distress was significantly associated with return to work 12 months after surgery (OR = 0.13; p < 0.01; 95% CI = 0.06–0.31), but it had no effect at the last survey wave (OR = 0.64; p = 0.31; 95% CI = 0.28–1.50). One year after surgery, education at higher levels had no significant effects on return to work (OR = 1.30; p = 0.57; 95% CI = 0.56–3.00 for the highest level compared with the lowest one), only at the last measurement marked differences by education emerged (OR = 2.23; p = 0.03; 95% CI = 1.08–4.63). Conclusion: Temporal distance between surgery and survey wave determines whether potentially influencing factors have effects. Disease severity and post-surgical treatment were unrelated to employment. Whether work-related and socio-demographic factors are determining employment depends on the date of measurement.


  • Open Access

    Body image of men and women with congenital heart disease over a 15 years observational period

    by Siegfried Geyer, Claudia Dellas, Elmar Brähler, Johannes Beller

    Most studies devoted to the psychological consequences of congenital heart disease (CHD) have dealt with consequences in terms of psychopathology. We wanted to consider two specific aspects of body image, “Rejecting body evaluation” and “Vital body dynamics”. We examined body image of CHD-patients as compared with the general population, the stability of body image of patients over time, and the relationship of body image with disease severity. The study combined a longitudinal (panel-) and a case-control design. The findings were based on a long-term study of CHD-patients with two surveys about 15 years apart with N = 244 who participated in both. The control group consisted of the same number of cases matched by age, gender and education drawn from a national survey designed to examine body image in the general population. More men than women were classified into the group with severe CHD. Body image differences between CHD-patients and controls were found only in men, but not in women, and they emerged primarily in terms of vitality. The two dimensions of body image turned out as moderately to strongly stable over time, relationships between disease severity and body image emerged only for perceived vitality. Contrary to expectation, effects of age and sex were largely absent. The body image of men turned out to be more affected by congenital heart disease than women. Body image is not stable, but it is changing with increasing age, and disease severity is affecting body image only in terms of the perception of physical performance.


  • Open Access

    Social participation of women with breast cancer compared to the general population 5 years after primary surgery—what role do medical data and cancer-related complaints play?

    by Stefanie Sperlich, Dorothee Noeres, Sophia Holthausen-Markou, Tjoung-Won Park-Simon, Eranda Sahiti, Siegfried Geyer

    Purpose: This study analyzes levels of social participation in patients with breast cancer on average 5 years following primary surgery as compared to women in the general population. In addition, the role of breast cancer-related complaints and medical data as possible influencing factors on levels of patients’ social participation is investigated. Methods: A total of n = 454 patients after primary surgery (t0) were recruited for a third follow-up study, and n = 372 completed this survey (t3), corresponding to a response rate of 82.2%. For measuring breast cancer-related complaints, participants completed a written questionnaire. Social participation was measured by a questionnaire on different leisure activities that was taken from the Socio-Economic Panel Study. Medical information was extracted from medical reports at t0. A principal component analysis was carried out to identify different dimensions of social participation. Chi2-tests and logistic regression analyses were applied to analyze social participation as compared to the general population and the role of possible medical and diagnosis-related influencing factors thereby. Results: Compared to the general population, patients show lower levels of social participation in the domains “socio-cultural participation” and “participation in institutions,” while no significant differences for “social participation in the private sphere” and “social participation via social media” were found. Psychological symptoms, pain, and a history of mastectomy were most strongly associated with restrictions in social participation. Conclusions: Our study suggests that social withdrawal may happen due to disease-related symptoms, preventing some breast cancer patients from participating fully in society. Cancer-related follow-ups should address this issue and support patients’ reintegration into society through appropriate therapeutic interventions.


  • Open Access

    Decreasing COPD-related incidences and hospital admissions in a German health insurance population

    by Siegfried Geyer, Juliane Tetzlaff, Stefanie Sperlich, Batoul Safieddine, Jelena Epping, Sveja Eberhard, Jona Stahmeyer, Johannes Beller

    Chronic obstructive pulmonary disease (COPD) is associated with smoking and work-related health hazards. Most studies have reported prevalences, and the number of studies examining incidences and social inequalities is small. We analyzed the development of social inequalities of COPD-incidences in terms of income and exacerbations in terms of hospital admissions. Findings were based on claims data from a German statutory health insurance covering 2008 to 2019. Outpatient diagnoses were used for defining COPD-cases, hospital admissions were used for detecting exacerbations. Analyses were performed using Cox-regression. Individual incomes were depicted at three levels defined according to national averages for each year. Data of 3,040,137 insured men and women were available. From 2008 to 2019 COPD-incidences in men decreased by 42% and 47% in women. After stratification by income the reduction at the lowest income level was 41% and 50% in women. Respectively, at the highest income level reductions were 28% and 41%. Disease exacerbations decreased over time, and also social inequalities between income groups emerged. COPD-rates decreased over time at all income levels, but at a faster pace in the lowest income group, thus leading to a positive development of diminishing social gradients in men as well as in women.


  • Open Access

    Health-Related Quality of Life in Patients With Ventricular Assist Device

    by Hannah Dsc Spielmann, Katharina Tigges-Limmer, Wolfgang Albert, Christine Msc Spitz-Köberich, Sandra Dipl-Psych Semmig-Könze, Paulina Msc Staus, on behalf of the Selma Study Group, Christoph Herrmann-Lingen, Kristin E. Sandau, Brynn Msc Okeson, et al.

    Background: Ventricular assist device (VAD) implantation has become an alternative treatment for patients with end-stage heart failure. In Germany, valid and reliable instruments to assess health-related quality of life in patients with VAD are lacking. Objective: The aim of this study was to present the psychometric validation of the German version of the Quality of Life with a Ventricular Assist Device questionnaire. Methods: In a multicenter, cross-sectional study, 393 participants (mean age, 58.3 years; 85.8% male, 60.3% bridge to transplant, and 72.8% living with VAD for ≤2 years) completed the German Quality of Life with a Ventricular Assist Device questionnaire of physical, emotional, social, cognitive, and meaning/spiritual domains. Item and confirmatory factor analyses were conducted to test item difficulty and discrimination and the underlying structure, respectively. To examine internal consistency, Cronbach α was assessed. Convergent construct validity was tested using the Kansas City Cardiomyopathy Questionnaire and the Patient Health Questionnaire-9. Readability was examined using Flesch Reading Ease index and Vienna Factual Text Formula. Results: The Quality of Life with a Ventricular Assist Device showed reasonable item difficulty (P total = .67) and mostly moderate to high discriminatory power (r it > 0.30). In confirmatory factor analysis, root-mean-square error of approximation (0.07) was acceptable for model fit, but no other indices. Acceptable internal consistency was found (α ≥ 0.79), with the exception of the cognitive domain (α = 0.58). The overall questionnaire and single domains demonstrated convergent validity (r ≥ 0.45, P < .001). The questionnaire showed adequate readability (Flesch Reading Ease, 64.11; Vienna Factual Text Formula, 6.91). Conclusion: Findings indicate a promising standardized clinical instrument to assess health-related quality of life in patients with VAD.


  • Open Access

    Trends of healthy and unhealthy working life expectancy in Germany between 2001 and 2020 at ages 50 and 60: a question of educational level?

    by Stefanie Sperlich, Johannes Beller, Jelena Epping, Siegfried Geyer, Juliane Tetzlaff

    Background Extending the number of active working years is an important goal both for maintaining individual quality of life and safeguarding social security systems. Against this background, we examined the development of healthy and unhealthy working life expectancy (HWLE/UHWLE) in the general population and for different educational groups. Methods The study is based on data from the German Socio-Economic Panel study, including 88 966 women and 85 585 men aged 50–64 years and covering four time periods (2001–05, 2006–2010, 2011–2015 and 2016–2020). Estimates of HWLE and UHWLE in terms of self-rated health (SRH) were calculated using the Sullivan’s method. We adjusted for hours worked and stratified by gender and educational level. Results Working-hours adjusted HWLE at age 50 increased in women and men from 4.52 years (95% CI 4.42 to 4.62) in 2001–2005 to 6.88 years (95% CI 6.78 to 6.98) in 2016–2020 and from 7.54 years (95% CI 7.43 to 7.65) to 9.36 years (95% CI 9.25 to 9.46), respectively. Moreover, UHWLE also rose with the proportion of working life spent in good SRH (health ratio) remaining largely stable. At age 50, educational differences in HWLE between the lowest and highest educational groups increased over time in women and in men from 3.72 to 4.99 years and from 4.06 to 4.40 years, respectively. Conclusions We found evidence for an overall increase but also for substantial educational differences in working-hours adjusted HWLE, which widened between the lowest and highest educational group over time. Our findings suggest that policies and health prevention measures at workplace should be more focused on workers with low levels of education in order to extend their HWLE.


  • Open Access

    Trends of Antidiabetic and Cardiovascular Diseases Medication Prescriptions in Type 2 Diabetes between 2005 and 2017—A German Longitudinal Study Based on Claims Data

    by Batoul Safieddine, Florian Trachte, Stefanie Sperlich, Jelena Epping, Karin Lange, Siegfried Geyer

    Background: With an attempt to understand possible mechanisms behind the severity-dependent development of type 2 diabetes (T2D) comorbidities, this study examines the trends of antidiabetic and cardiovascular diseases (CVD) medication prescriptions in individuals with T2D. Methods: The study is based on claims data from a statutory health insurance provider in Lower Saxony, Germany. The period prevalence of antidiabetic and CVD medication prescriptions was examined for the periods 2005–2007, 2010–2012, and 2015–2017 in 240,241, 295,868, and 308,134 individuals with T2D, respectively. (Ordered) logistic regression analyses were applied to examine the effect of time period on the number and prevalence of prescribed medications. Analyses were stratified by gender and three age groups. Results: The number of prescribed medications per person has increased significantly for all examined subgroups. For the two younger age groups, insulin prescriptions decreased but those of non-insulin medications increased, while both increased significantly over time for the age group of 65+ years. Except for glycosides and antiarrhythmic medications, the predicted probabilities for CVD medications increased over the examined periods, with lipid-lowering agents demonstrating the highest increase. Conclusions: Results point towards an increase in medication prescriptions in T2D, which is in line with the evidence of the increase in most comorbidities indicating morbidity expansion. The increase in CVD medication prescriptions, especially lipid-lowering agents, could explain the specific development of severe and less severe T2D comorbidities observed in this population.